|
Volumn 31, Issue 1, 2008, Pages 2-18
|
Effects of nebicapone on levodopa pharmacokinetics, catechol-O- methyltransferase activity, and motor fluctuations in patients with Parkinson disease
e
4Health Ltd
(Portugal)
|
Author keywords
Clinical trial; COMT inhibitors; Entacapone; Nebicapone; Parkinson disease
|
Indexed keywords
3 O METHYLDOPA;
CARBIDOPA PLUS LEVODOPA;
CATECHOL METHYLTRANSFERASE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
ENTACAPONE;
LEVODOPA;
NEBICAPONE;
PLACEBO;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AGGRESSION;
AGITATION;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG TOLERABILITY;
ENZYME ACTIVITY;
FALLING;
FEMALE;
HALLUCINATION;
HUMAN;
HYPOMANIA;
LIVER FUNCTION TEST;
MALE;
MOTOR PERFORMANCE;
NAUSEA;
PARKINSON DISEASE;
PHARMACODYNAMICS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SOMNOLENCE;
SWEATING;
TACHYCARDIA;
TREATMENT DURATION;
URINE;
VOMITING;
ACETOPHENONES;
ADULT;
AGED;
ANTIPARKINSON AGENTS;
CARBIDOPA;
CATECHOL O-METHYLTRANSFERASE;
CATECHOLS;
CROSS-OVER STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG INTERACTIONS;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
LEVODOPA;
MALE;
MIDDLE AGED;
MOTOR ACTIVITY;
NITRILES;
PARKINSON DISEASE;
PLACEBOS;
|
EID: 40049104890
PISSN: 03625664
EISSN: None
Source Type: Journal
DOI: 10.1097/wnf.0b013e3180645cb0 Document Type: Article |
Times cited : (30)
|
References (36)
|